SNCA and Parkinson disease: For example, SNCA methylation was found to be increased in peripheral blood of PD patients who received higher L-dopa dosage, suggesting that its pharmacological action was not limited to the dopamine precursor function but included epigenetic off-target effects detectable also in peripheral blood [30].